Primary hyperparathyroidism and osteoporosis in 2004

Joint Bone Spine

Volumn 71, Issue 3, 2004, Pages 183-189

  Cormier, Catherine ^a   Souberbielle, Jean Claude ^b   Kahan, André ^a  

^a Institut Cochin   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Osteoporosis; Primary hyperparathyroidism

Indexed keywords

CALCIMIMETIC AGENT; PARATHYROID HORMONE; PHOSPHONIC ACID DERIVATIVE; RALOXIFENE;

BONE DENSITY; BONE MINERAL; DIAGNOSTIC PROCEDURE; DISEASE PREDISPOSITION; ESTROGEN THERAPY; FRACTURE; HORMONE DETERMINATION; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; MORPHOMETRICS; MORTALITY; OSTEOPENIA; OSTEOPOROSIS; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; TREATMENT INDICATION;

EID: 2942550632     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2003.09.012     Document Type: Short Survey

References (42)

1. Al Zahrani A., Levine M.A. Primary hyperparathyroidism. Lancet. 349:1997;1233-1238
2. Wermers R.A., Khosla S., Atkinson E.J., Hodgson S.F., O'Fallon W.M., Melton L.J. III. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med. 126:1997;433-440
3. Glendenning P., Gutteridge D.H., Retallack R.W., Stuckey B.G.A., Kermode D.G., Kent G.N. High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria. Aust NZ J Med. 28:1998;173-178
4. Duh Q.Y., Arnaud C.D., Levin K.E., Clark O.H. Parathyroid hormone: before and after parathyroidectomy. Surgery. 100:1986;1021-1031
5. Ljunghall S., Larsson K., Lindh E., Lindqvist U., Rastad J., Akerström G., et al. Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism. Surgery. 110:1991;47-53
6. Carnaille B., Oudar C., Pattou F., Quierreux J., Proye C. Improvements in parathyroid surgery in the intact 1-84 PTH assay era. Aust NZ J Surg. 68:1998;112-116
7. Gardin J.P., Paillard M. Normocalcemic primary hyperparthyroidism: resistance to PTH effect on tubular reabsorption of calcium. Miner Electrolyte Metab. 10:1984;301-308
8. Souberbielle J.C., Cormier C., Kindermans C., Gao P., Cantor T., Forette F., et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab. 86:2001;3086-3090
9. Souberbielle J.C., Lawson-Body E., Hammadi B., Sarfati E., Kahan A., Cormier C. The use in clinical practice of PTH normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Met. 3:2004;501-504
10. Christiansen P., Steiniche T., Brixen K., Hessov I., Melsen F., Charles P., et al. Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone. 21:1997;93-99
11. Nakaoka D., Sugimoto T., Kobayashi T., Yamaguchi T., Kobayashi A., Chihara K. Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 85:2000;1901-1907
12. Rao D.S., Agarwal G., Talpos G.B., Philipps E.R., Bandeira F., Mishra S.K., et al. Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res. 17:2002;N75-80
13. Silverberg S.J., Bilezikian J.P., Bone H.G. III, Talpos G.B., Horwitz M.J., Stewart A.F. Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab. 84:1999;2275-2285
14. Rao D.S., Honasoge M., Divine G.W., Phillips E.R., Lee M.W., Ansari M.R., et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implcations. J Clin Endocrinol Metab. 85:2000;1054-1058
15. Harinarayan C.V., Gupta N., Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf). 43:1995;351-358
16. Silverberg S.J., Shane E., Dempster D.W., Bilezikian J.P. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med. 107:1999;561-567
17. Silverberg S.J., Shane E., De La Cruz L., Dempster D.W., Feldman F., Seldin D., et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res. 4:1989;283-291
18. Kantorovich V., Gacad M.A., Seeger L.L., Adams J.S. Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endicrinol Metab. 85:2000;3541-3543
19. Silverberg S.J., Gartenberg F., Jacobs T.P., Shane E., Siris E., Staron R.B., et al. Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab. 80:1995;723-728
20. Silverberg S.J., Locker F.G., Bilezikian J.P. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab. 81:1996;4007-4012
21. Abdelhadi M., Nordenström J. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab. 83:1998;3845-3851
22. Minisola S., Rosso R., Scarda A., Pacitti M.T., Romagnoli E., Mazzuoli G. Quantitative ultrasound assessment of bone in patients with primary hyperparathyroidism. Calcif Tissue Int. 56:1995;526-528
23. Cortet B., Cortet C., Blanckaert F., Racadot A., d'Herbomez M., Marchandise X., et al. Bone ultrasonometry and turnover markers in primary hyperparathyroidism. Calcif Tissue Int. 66:2000;11-15
24. Gonnelli S., Montagnani A., Cepollaro C., Monaco R., Gennari L., Rossi B., et al. Quantitative ultrasound and bone mineral density in patients with primary hyperparathyroidism before and after surgical treatment. Osteoporos Int. 11:2000;255-260
25. Guo C.Y., Thomas W.E.G., Al-Dehaimi A.W., Assiri A.M.A., Eastell R. Longitudinal changes in bone mineral density and bone turnover in post menopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab. 81:1996;3487-3491
26. Orr-Walker B.J., Evans M.C., Clearwater J.M., Horne A., Grey A.B., Reid I.R. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women. Arch Intern Med. 160:2000;2161-2166
27. Silverberg S.J., Shane E., Jacobs T.P., Siris E., Bilezikian J.P. A 10-year prospective study of primary hyperparathyroidism with and without parathyroid surgery. N Engl J Med. 341:1999;1249-1255
28. Silverberg S.J., Gartenberg F., Jacobs T.P., Shane E., Siris E., Staron R.B., et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab. 80:1995;729-734
29. Vestergaard P., Mollerup C.L., Frokjaer V.G., Christiansen P., Blichert-Toft M., Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ. 321:2000;598-602
30. Eriksen E.F. Primary hyperparathyroidism: lessons from bone histomorphometry. J Bone Miner Res. 17:2002;N95-N97
31. Mautalen C., Reyes H.R., Ghiringhelli G., Fromm G. Cortical bone mineral content in primary hyperparathyroidism. Changes after parathyroidectomy. Acta Endocrinol. 11:1986;494-497
32. Hesp R., Tellez M., Davidson L., Elton A., Reeve J. Trabecular and cortical bone in the radii of women with parathyroid adenomata: a greater trabecular deficit, with a preliminary assessment of recovery parathyroidectomy. Bone Miner. 2:1987;301-310
33. Miller P.D., Bilezikian J.P. Bone densitometry in asymptomatic primary hyperparathyroidism. Bone Miner. 17:2002;N98-102
34. Melton L.J. III, Atkinson E.J., O'Fallon W.M., Heath H. III. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med. 152:1992;2269-2273
35. Larsson K., Ljunghall S., Krusemo U.B., Naessen T., Lindh E., Persson I. The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. J Intern Med. 234:1993;585-593
36. Kenny A.M., MacGillivray D.C., Pilbeam C.C., Crombie H.D., Raisz L.G. Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery. 118:1995;109-114
37. Khosla S., Melton L.J. III, Wermers R.A., Crowson C.S., O'Fallon W.M., Riggs B.L. Primary hyperparathyroidism and the risk of fracture: a population-based study. J. Bone Miner Res. 14:1999;1700-1707
38. Bilezikian J.P., Potts J.T., Fuleihan Gel.H., Kleerekoper M., Neer R., Peacock M., et al. Summary, statement from a workshop an asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res. 17:2002;N2-11
39. Rubin M.R., Lee K.H., McMahon D.J., Silverberg S.J. Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab. 88:2003;1174-1178
40. Rodan G.A. Bisphosphonates and primary hyperparathyroidism. J Bone Miner Res. 17:2002;N150-N153
41. Antoniucci D.M., Shoback D. Calcimimetics in the treatment of primary hyperparathyroidism. 17:2002;N141-N145
42. Tannenbaum C., Clark J., Schwartzman K., Wallenstein S., Lapinsky R., Meier D., et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab. 87:2002;4431-4437